SEC Contract Filing

Filing Date: 2023-11-22

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>tm2331127d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-weight: bold; text-align: right; margin: 0">Exhibit 10.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDMENT TO LEAK-OUT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This SECOND AMENDMENT TO LEAK-OUT
AGREEMENT, dated November&nbsp;21, 2023 (this <I>&ldquo;<B>Amendment</B>&rdquo;</I>) is entered into by and between DIGITAL HEALTH ACQUISITION
CORP., a Delaware corporation (the <I>&ldquo;<B>Company</B>&rdquo;</I>) and SALESFORCE,&nbsp;INC. (the &ldquo;<B><I>Holder</I></B>&rdquo;).
Capitalized terms used herein, unless otherwise defined, shall have the meanings set forth in the Leak-Out Agreement, dated August&nbsp;9,
2022, by and between the Company and the Holder, as amended on October&nbsp;6, 2022 (the &ldquo;<B><I>Original Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company is entering
into that certain Third Amended and Restated Business Combination Agreement, dated November&nbsp;21, 2023, by and among the Company, Merger
Sub I, Merger Sub II, VSee, and iDoc (as amended, the &ldquo;<B><I>A&amp;R BCA</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the A&amp;R BCA, the Company and the Holder desire to amend the Original Agreement to modify clause (iii)&nbsp;of the definition of &ldquo;Restricted
Period&rdquo; in the Original Agreement to be consistent with restrictions set forth in the Lock-Up Agreement (as defined in the A&amp;R
BCA), pursuant to and in accordance with this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, the Company
and the Holder mutually agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fourth paragraph of the
Original Agreement is hereby amended and restated in its entirety to read as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
Holder agrees solely with the Company that from the Closing Date and ending at the earliest of <B>(i)</B>&nbsp;4:00 pm (New York City
time) on <B>July&nbsp;31, 2024</B>, <B>(ii)</B>&nbsp;at such time as the aggregate volume since, and including, the Closing Date exceeds
10,000,000 shares of common stock on the NASDAQ as reported by Bloomberg, LP, <B>(iii)</B>&nbsp;(a)&nbsp;180 days after the Closing (as
defined in the A&amp;R BCA), or (b)&nbsp;subsequent to the Closing, (1)&nbsp;if the last reported sale price of DHAC&rsquo;s common stock
equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for
any 20 trading days within any 30 consecutive trading days after the Closing, the date after such 20<SUP>th</SUP> trading day or (2)&nbsp;the
date on which DHAC completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of
DHAC&rsquo;s public stockholders having the right to exchange their shares of DHAC common stock for cash, securities or other property,
or <B>(iv)</B>&nbsp;the termination of the PIPE Lock-up Agreement </FONT>(as defined in the A&amp;R BCA) (such period, the &ldquo;<U>Restricted
Period</U>&rdquo;), neither the Holder, nor any affiliate of such Holder which <B>(a)</B>&nbsp;had or has knowledge of the transactions
contemplated by the A&amp;R BCA, <B>(b)</B>&nbsp;has or shares discretion relating to such Holder&rsquo;s investments or trading or information
concerning such Holder&rsquo;s investments, including in respect of the Securities, or <B>(c)</B>&nbsp;is subject to such Holder&rsquo;s
review or input concerning such affiliate&rsquo;s investments or trading (together, the &ldquo;<U>Holder&rsquo;s Trading Affiliates</U>&rdquo;),
collectively, shall sell, dispose or otherwise transfer, directly or indirectly, (including, without limitation, any sales, short sales,
swaps or any derivative transactions that would be equivalent to any sales or short positions) on any Trading Day during the Restricted
Period (any such date, a &ldquo;<U>Date of Determination</U>&rdquo;), common stock of the Company issued to the Holder on the Closing
Date in connection with the transactions contemplated by the A&amp;R BCA (the &ldquo;<U>Restricted Securities</U>&rdquo;), in an amount
representing more than 10% of the trading volume of common stock of the Company as reported by Bloomberg, LP on the applicable Date of
Determination.&rdq